Home  - Basic_G - Graft Vs Host Disease

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

41-60 of 90    Back | 1  | 2  | 3  | 4  | 5  | Next 20

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Graft Vs Host Disease:     more books (19)

Graft-Vs.-Host Disease: Immunology, Pathophysiology, and Treatment (Hematology) by Steven J. Burakoff, 1990-07 Graft vs. Host Disease, Third Edition Graft-vs.-Host Disease: An entry from Gale's <i>Gale Encyclopedia of Medicine, 3rd ed.</i> by J., MD Polsdorfer, 2006 Gale Encyclopedia of Cancer: Graft-vs.-host disease by M.S. Jill Granger, 2002-01-01 Immunosuppressive Tx may get boost from adjunctive use of ECP. (Promising for Graft-vs.-Host Disease).(extracorporeal photophoresis ): An article from: Skin & Allergy News by Mitchel L. Zoler, 2003-07-01 Gale Encyclopedia of Medicine: Graft-vs.-host disease by J. Ricker Polsdorfer MD, 2002-01-01 Graft-vs.-host disease: An entry from Thomson Gale's <i>Gale Encyclopedia of Cancer, 2nd ed.</i> by J., M.D. Polsdorfer, Jill, M.S. Granger, 2006 Graft vs. Host Disease, Third Edition by James Ferrara, 1980 Chronic Graft Versus Host Disease: Interdisciplinary Management Graft-Versus-host Disease (Medical Intelligence Unit) by Ph.D., M.D. Nelson J. Chao, 1999-03-15 Talking Points in Dermatology - I (New Clinical Applications: Dermatology) (No. 1) Practical Hematopoietic Stem Cell Transplantation Clinical and Diagnostic Pathology of Graft-versus-Host Disease by Berno Heymer, 2002-05-03 Clinical evidence of autologous graft versus tumor effect.(Report): An article from: American Journal of Immunology by Luis F. Porrata, 2009-01-01

lists with details

41. BioSpace : CCIS : Search Results For Indication = 'Graft Vs. Host Disease'
    approved products, please log in above or subscribe. 13 Search Results for Indication = graft vs. host disease . View as worksheet.  
    http://www.biospace.com/ccis/search.cfm?RXTargetID=57004

42. Graft-vs.-host Disease
    graftvs.-host disease is an immune attack on the recipient by cells from a donor. donor and recipient are well matched, graft-vs.-host disease can still occur  
    http://www.chclibrary.org/micromed/00049690.html
    
    Extractions: The main problem with transplanting organs and tissues is that the recipient host does not recognize the new tissue as its own. Instead, it attacks it as foreign in the same way it attacks germs, to destroy it. If immunogenic cells from the donor are transplanted along with the organ or tissue, they will attack the host, causing graft vs. host disease. The only transplanted tissues that house enough immune cells to cause graft vs. host disease are the blood and the bone marrow. Blood transfusions are used every day in hospitals for many reasons. Bone marrow transplants are used to replace blood forming cells and immune cells. This is necessary for patients whose cancer treatment has destroyed their own bone marrow. Because bone marrow cells are among the most sensitive to radiation and chemotherapy , it often must be destroyed along with the cancer. This is true primarily of leukemias, but some other cancers have also been treated this way. Even if the donor and recipient are well matched, graft-vs.-host disease can still occur. There are many different elements involved in generating immune reactions, and each person is different, unless they are identical twins. Testing can often find donors who match all the major elements, but there are many minor ones that will always be different. How good a match is found also depends upon the urgency of the need and some good luck.

43. Gale Encyclopedia Of Medicine Graft-vs.-host Disease
    graftvs.-host disease. The only transplanted tissues that house enough immune cells to cause graft vs. host disease are the blood and the bone marrow.  
    http://www.findarticles.com/cf_0/g2601/0006/2601000605/p1/article.jhtml
    
    Extractions: Print friendly Tell a friend Find subscription deals by J. Ricker Polsdorfer Graft-vs.-host disease is an immune attack on the recipient by cells from a donor. The main problem with transplanting organs and tissues is that the recipient host does not recognize the new tissue as its own. Instead, it attacks it as foreign in the same way it attacks germs, to destroy it. If immunogenic cells from the donor are transplanted along with the organ or tissue, they will attack the host, causing graft vs. host disease. The only transplanted tissues that house enough immune cells to cause graft vs. host disease are the blood and the bone marrow. Blood transfusions are used every day in hospitals for many reasons. Bone marrow transplants are used to replace blood forming cells and immune cells. This is necessary for patients whose cancer treatment has destroyed their own bone marrow. Because bone marrow cells are among the most sensitive to radiation and chemotherapy, it often must be destroyed along with the cancer. This is true primarily of leukemias, but some other cancers have also been treated this way. Even if the donor and recipient are well matched, graft-vs.-host disease can still occur. There are many different elements involved in generating immune reactions, and each person is different, unless they are identical twins. Testing can often find donors who match all the major elements, but there are many minor ones that will always be different. How good a match is found also depends upon the urgency of the need and some good luck.

44. Photopheresis For Chronic Graft Vs. Host Disease
    Photopheresis for Chronic graft vs. host disease. This educational resource is supported by an unrestricted educational grant from therakos.logo.gif  
    http://www.bloodline.net/stories/storyReader$3374

45. Extracorporeal Phtopheresis In Acute Graft Vs. Host Disease
    Extracorporeal Phtopheresis in Acute graft vs. host disease. This educational resource is supported by an unrestricted educational grant from therakos.logo.gif  
    http://www.bloodline.net/stories/storyReader$3375

46. Acute And Chronic Syngeneic Graft-vs-Host Disease
    Acute and Chronic Syngeneic graftvs-host disease. Complexity of Effector Mechanisms in Cyclosporine-Induced Syngeneic graft-vs-host disease.  
    http://bbmt.cjp.com/stories/storyReader$51
    
    Extractions: Journal Center Complexity of Effector Mechanisms in Cyclosporine-Induced Syngeneic Graft-vs-Host Disease Allan D. Hess, Christopher J. Thoburn, Weiran Chen and Louis R. Horwitz Administration of the immunosuppressive drug, cyclosporine after syngeneic or autologous bone marrow transplantation elicits a T-lymphocyte-dependent autoimmune syndrome similar to graft-vs-host disease (GVHD). The onset of this autoaggression syndrome, termed syngeneic GVHD, is associated with the development of a highly restricted repertoire of CD8 autoreactive T cells that recognize a peptide from the invariant chain, termed CLIP, presented by MHC class II molecules. Clonal analysis reveals two distinct subsets of autoreactive T cells defined by their activation requirement for either the N terminal or the C terminal flanking regions of CLIP and by their cytokine profile. The present studies reveal that the autoreactive T cell clones requiring the N terminal flanking region of CLIP produce type 1 cytokines (interferon [IFN]- y , interleukin [IL]-2, and tumor necrosis factor- a ). In contrast, the autoreactive T cell clones that require the C terminal flanking region of CLIP produce type 2 cytokines (IL-4, IL-10, Transforming growth factor-

47. Lymphohematopoietic Graft-vs.-Host Reactions Without GVHD
    Lymphohematopoietic graftvs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based  
    http://bbmt.cjp.com/stories/storyReader$96
    
    Extractions: Journal Center Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen Michele R. Pelot, Denise A. Pearson, Kirsten Swenson, Guiling Zhao, Jessica Sachs, Yong-Guang Yang, Megan Sykes 5.3.Pelot Carden Jennings Publishing Co., Ltd. Current Edition

48. Learn About Cord Blood, Stem Cells, And Us
    cells? Q What are possible uses of cord blood stem cells in the future? Q What is graft vs. host disease (GVHD)? A graft vs. host  
    http://www.cordbloodfamilytrust.com/faq/index.cfm?faqID=84

49. ASCO - Browse By Meeting - Alemtuzumab Prevents Acute Graft-vs.-host Disease (aG
    globulin and corticosteroids to methotrexate and cyclosporine (or tacrolimus) does not change the rates of acute graftvs-host disease, early infections  
    http://www.asco.org/ac/1,1003,_12-002636-00_18-0023-00_19-00101296,00.asp?Abstra

50. Genomics|HuGENet EJournal On Graft Vs Host Abstract
    none. Health outcome(s) Identification of the major health outcome(s) studied, Acute graft versus host disease (GVHD), grade III or IV;  
    http://www.cdc.gov/genomics/hugenet/ejournal/GraftVsHostAbst.htm
    
    Extractions: The authors study hypotheses or main purpose for conducting the study Hypothesis: Polymorphisms in cytokine promoter regions that enhance or suppress cytokine expression may affect the severity of the inflammatory response involved in GVHD and associated survival. This study is meant to replicate the findings of other studies showing associations between a variety of cytokine promoter-region single-nucleotide polymorphisms and GVHD outcomes Gene(s)

51. Blackwell Synergy - Cookie Absent
    This article reviews acute graft vs. host disease (GVHD) as a complication of orthotopic liver transplantation (OLT). The incidence  
    http://www.blackwell-synergy.com/links/doi/10.1111/j.1600-6143.2004.00406.x/enha
    
    Extractions:  Home An Error Occurred Setting Your User Cookie A cookie is a small amount of information that a web site copies onto your hard drive. Synergy uses cookies to improve performance by remembering that you are logged in when you go from page to page. If the cookie cannot be set correctly, then Synergy cannot determine whether you are logged in and a new session will be created for each page you visit. This slows the system down. Therefore, you must accept the Synergy cookie to use the system. What Gets Stored in a Cookie? Synergy only stores a session ID in the cookie, no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a web site to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. Please read our for more information about data collected on this site.

52. Dermatology Times : Photochemotherapy Relieves Case Of Graft Vs. Host Disease.(B
    Dermatology Times Photochemotherapy Relieves Case of graft vs. host disease.(Brief Article) @ HighBeam Research. Read Dermatology  
    http://static.highbeam.com/d/dermatologytimes/april012000/photochemotherapyrelie

53. Graft-vs-Host Disease : On Medical Dictionary Online
    graftvs-host disease defined on the Free Online Medical Dictionary. Medical terminology definitions graft-vs-host disease. The clinical entity  
    http://www.online-medical-dictionary.org/?q=Graft-vs-Host Disease

54. Clinical Trial: Sargramostim In Reducing Graft-Versus-Host Disease In Patients W
    Determine the efficacy of sargramostim (GMCSF) to mobilize CD34+ hematopoietic stem cells in donors and to reduce graft-vs-host disease in patients after  
    http://www.clinicaltrials.gov/ct/gui/show/NCT00053157?order=50

55. Graft Versus Host Disease GVHD
    Clinical Significance of Skin Biopsies in the Diagnosis and Management of graftvs-host disease in Early Postallogeneic Bone Marrow Transplantation Youwen Zhou  
    http://www.edae.gr/graft.html
    
    Extractions: HELLENIC ASSOCIATION DERMATOLOGY - VENEREOLOGY GRAFT VERSUS HOST DISEASE (GVHD) Acute Graft Versus Host Disease Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect Advances in Small Bowel and Multivisceral Transplantation Jacques Pirenne, MD, PhD. XVIII International Congress of the Transplantation Society Approaches to Treating Graft-Versus-Host Disease Approaches to Treating Graft-Versus-Host Disease. Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation Public Health Service National Institutes of Health bone marrow transplants Bullous Esophagitis and GVHD diagnosishealth. BULLOUS ESOPHAGITIS DUE TO CHRONIC GVHD Causes, incidence, and risk factors graft-versus-host reaction Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. Grundmann-Kollmann M, Behrens S, Gruss C, Gottlober P, Peter RU, Kerscher M. Department of Dermatology, University of Ulm, Germany. J Am Acad Dermatol 2000 Jan; 42(1 Pt 1): 134-6. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy Grundmann-Kollmann M, Behrens S, Gruss C: J Am Acad Dermatol 2000 Jan; 42(1 Pt 1): 134-6[Medline].

56. Graft Vs. Host Disease Study: News: UI Health Care
    Health Care researcher is serving as a coprincipal investigator for a National Institutes of Health (NIH) grant to study graft versus host disease (GVHD) in  
    http://www.uihealthcare.com/news/news/2001/01/22graft.html
    
    Extractions: staff@uihealthcare.com University of Iowa UI Health Care News: Week of January, 2001 A University of Iowa Health Care researcher is serving as a co-principal investigator for a National Institutes of Health (NIH) grant to study Graft versus Host Disease (GVHD) in children. GVHD is a common and life-threatening complication that can follow bone marrow transplantation. Frederick Goldman, M.D., UI associate professor of pediatrics and director of the UI Pediatric Bone Marrow Transplant Unit, received $460,000 of the $2.3 million, five-year NIH grant for his component of the study. The study's lead investigator is Andrew Gilman, M.D., of Children's Mercy Hospital in Kansas City, Mo. The overall study goals are to evaluate the effectiveness of hydroxychloroquine, a new immunosuppressive drug, for treating GVHD and to better under what causes the disease, Goldman said. More than 100 pediatric bone marrow transplant centers nationwide will participate in the trial, which is sponsored by the federal Children's Oncology Group. The study will ultimately involve more than 300 pediatric patients.

57. Graft-vs-Host Disease After Solid Organ Transplant
    graftvs-host disease (GVHD), a common complication of allogeneic bone marrow transplantation, also may be seen after solid organ transplantation and in  
    http://www.medscape.com/viewarticle/452197

58. Imaging In Bone Marrow Transplantation
    graftvs-host disease. GVHD is a significant posttransplantation complication that occurs in about 50% of allogeneic transplants.  
    http://www.medscape.com/viewarticle/417694_2

59. JW Dermatology -- Sign In
    Late Occurrence of graftvs-host disease. Valks R et al. Late appearance of acute graft-vs-host disease after suspending or tapering immunosuppressive drugs.  
    http://dermatology.jwatch.org/cgi/content/full/2001/227/2
    
    Extractions: All customers have full-text access to the Journal Watch publication(s) to which they have a subscription. Other registered users have access to Journal Watch Online content older than six months and may request e-mail notification of current contents. Subscribers and Registered Users User Name Password If you are a subscriber using Journal Watch Online for the first time you must activate and choose a password Remember my user name and password. Forgotten your password? If you do not use cookies sign in here (After you click the 'Sign In' button you may have to wait for several seconds. Thank you for your patience.)

60. Graft-Versus-Host Disease
    graftvs-host disease After Solid Organ Transplant Sclerodermatous graft-vs-host disease clinical and pathological study of 17 patients.  
    http://www.thedoctorsdoctor.com/diseases/graft_vs_host_disease.htm
    
    Extractions: Background Graft-versus-host disease (GVH) is a disease of modern medicine. It most commonly occurs in bone marrow transplant patients receiving an allogeneic transplant of immunocompetent lymphocytes. The donor cytotoxic T lymphocytes attack the recipient's organs including skin, gut, liver, and mucous membranes. It may occur in 50% of recipients of allogeneic bone marrow transplants. GVH may also occur after maternofetal blood transfusions, intrauterine exchange transfusions, and administration of non-irradiated blood products to patients with metastatic malignancies or with immunodeficiencies. OUTLINE Epidemiology Disease Associations Pathogenesis Gross Appearance and Clinical Variants ... Internet Links

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

41-60 of 90    Back | 1  | 2  | 3  | 4  | 5  | Next 20